AU6338999A - Combination of norpregnane derivatives and cyclodextrin - Google Patents

Combination of norpregnane derivatives and cyclodextrin

Info

Publication number
AU6338999A
AU6338999A AU63389/99A AU6338999A AU6338999A AU 6338999 A AU6338999 A AU 6338999A AU 63389/99 A AU63389/99 A AU 63389/99A AU 6338999 A AU6338999 A AU 6338999A AU 6338999 A AU6338999 A AU 6338999A
Authority
AU
Australia
Prior art keywords
cyclodextrin
combination
gestagen
derivatives
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63389/99A
Inventor
Thomas Backensfeld
Peter Hofert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU6338999A publication Critical patent/AU6338999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to a combination of at least one gestagen and a beta -cyclodextrin or an gamma -cyclodextrin or the derivatives of said cyclodextrins obtained by etherification or esterification of the free alcohol functions of cyclodextrin, wherein the gestagen is a bridged 4,17-C>2<-steroid. The gestagen is preferably (21S)-21-hydroxy-21-methyl-14,17-ethano-19-norpregna-4,9,15-triene-3,2 0-dion). The cyclodextrin is preferably beta -cyclodextrin. Said combination is used as medicament in the treatment of climateric complaints and fertility control.
AU63389/99A 1998-10-14 1999-10-13 Combination of norpregnane derivatives and cyclodextrin Abandoned AU6338999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19848303A DE19848303A1 (en) 1998-10-14 1998-10-14 Stable combination of 14,17-over-bridged steroid gestagen and cyclodextrin compound, useful for treating climacteric disorders or for contraception
DE19848303 1998-10-14
PCT/EP1999/007711 WO2000021570A1 (en) 1998-10-14 1999-10-13 Combination of norpregnane derivatives and cyclodextrin

Publications (1)

Publication Number Publication Date
AU6338999A true AU6338999A (en) 2000-05-01

Family

ID=7885041

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63389/99A Abandoned AU6338999A (en) 1998-10-14 1999-10-13 Combination of norpregnane derivatives and cyclodextrin

Country Status (5)

Country Link
EP (1) EP1121152B1 (en)
AT (1) ATE264115T1 (en)
AU (1) AU6338999A (en)
DE (2) DE19848303A1 (en)
WO (1) WO2000021570A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27088A1 (en) * 2000-12-20 2002-07-31 Schering Ag ESTROGEN-CYCLODEXTRINE COMPLEX COMPOSITIONS
EP1216713A1 (en) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
EP1216699A1 (en) * 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermal system comprising a highly potent progestin
DE10234525A1 (en) * 2002-07-25 2004-02-05 Schering Ag New compositions, useful as male contraceptives, comprise synergistic active agent combination of androgenic 11beta-halo-steroid and gestagenic 14 alpha, 17alpha-ethylene-estratrienone derivative
WO2004011008A1 (en) * 2002-07-25 2004-02-05 Schering Aktiengesellschaft COMPOSITION CONTAINING AN ANDROGENOUS 11β-HALOGEN STEROID AND A PROGESTATIONAL HORMONE, AND MALE CONTRACEPTIVE BASED ON SAID COMPOSITION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
NL8801670A (en) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan PHARMACEUTICAL PREPARATION.
WO1990001320A1 (en) * 1988-08-15 1990-02-22 American Maize-Products Company Water soluble branched beta cyclodextrin steroid complex
FR2667070A1 (en) * 1990-09-21 1992-03-27 Besins Iscovesco Labo STEROIDS INCLUDED IN CYCLODEXTRINS PROCESS FOR THEIR PREPARATION COMPLEXES AND CORRESPONDING GOLENIC FORMS AND THEIR THERAPEUTIC APPLICATIONS.
DE4426709A1 (en) * 1994-07-20 1996-01-25 Schering Ag Solid dosage forms containing steroidal sex hormones
DE4428654A1 (en) * 1994-08-12 1996-02-15 Consortium Elektrochem Ind Water soluble cyclodextrin derivatives with lipophilic substituents and process for their preparation
DE4447401A1 (en) * 1994-12-23 1996-07-04 Schering Ag 14.17-C¶2¶-bridged steroids

Also Published As

Publication number Publication date
EP1121152B1 (en) 2004-04-14
DE59909196D1 (en) 2004-05-19
WO2000021570A1 (en) 2000-04-20
EP1121152A1 (en) 2001-08-08
ATE264115T1 (en) 2004-04-15
DE19848303A1 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
EP0300526A3 (en) Antiviral pharmaceutical compositions containing cyclodextrins
KR870002842A (en) Containing Complexes of 7-Isopropoxy-Isoflavones Prepared from Cyclodextrins and Pharmacological Compositions and Preparations Containing the Active Ingredients
AU583599B2 (en) Novel derivatives of y-cyclodextrin
AU4693696A (en) Cross-linked polymers made from 1,3,7-octatriene and like conjugated polyenes
AU8090791A (en) Aminosteroids for ophthalmic use
AU7432094A (en) Process for the preparation of alkylated cyclodextrin derivatives, methylated cyclodextrin derivatives which can be prepared by the process, and the use of the products
EP1057862A3 (en) Polymer film compositions for capsules
AU7462891A (en) Alpha-cyanacrylate adhesive compositions
CA2119154A1 (en) Derivatives of Cyclodextrins Exhibiting Enhanced Aqueous Solubility and the Use Thereof
ATE483480T1 (en) ACID SUPERABSORBENT POLYSACCHARIDES
EP0803243A3 (en) Cyclodextrins and phenolic compounds in dental products
BR9710353A (en) 6,7-oxygenated steroids and related uses.
AU8679198A (en) Modified polylactide compositions, water-responsive, biodegradable films and fibers comprising polylactide and poly(vinyl alcohol) and methods for making the same
AU3932400A (en) Enhanced gel strength methylcellulose
FI932626A (en) The pathogenic antigenic polysaccharides are derived from oligosaccharides
AU6338999A (en) Combination of norpregnane derivatives and cyclodextrin
ATE202572T1 (en) NOVEL CELLULOSE ETHERS AND METHOD FOR THE PRODUCTION THEREOF
AU4293199A (en) A process for making paper
AU2001268964A1 (en) Polysaccharide - based superabsorbent film
HU9203649D0 (en) Method for producing inclusion compounds of nimesulide with cyclodextrines and pharmaceutical preparatives containing these compounds
AU699482B2 (en) Derivatives of cyclodextrins, their preparation and their use for incorporating hydrophobic molecules into organized surfactant systems
BR0212027A (en) Container having improved barrier organoleptic properties
NO20005492L (en) Dextrin-containing preparation for the prevention of surgical adhesions
HUP0300185A2 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins
刘勇 et al. Water-soluble crosslinked β-cyclodextrin polymer inclusion complexes with C60

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase